Pancreatic Research Group,
South Western Sydney Clinical School,
Pancreatic Research Group, South Western Sydney Clinical School
medical oncologist, clinical trials,clinical and translational research experience
Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification.
The Journal of infectious diseases Sep, 1998 | Pubmed ID: 9728559
Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians.
Social science & medicine (1982) Jul, 2004 | Pubmed ID: 15110416
Modern management of pancreatic carcinoma.
Internal medicine journal Aug, 2004 | Pubmed ID: 15317546
Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach.
Psycho-oncology Mar, 2005 | Pubmed ID: 15386778
Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.
British journal of cancer Mar, 2005 | Pubmed ID: 15756253
Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines.
Cancer letters Jul, 2005 | Pubmed ID: 15922858
Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Oncology , 2005 | Pubmed ID: 16293972
Phase II study of vinflunine in patients with metastatic renal cell carcinoma.
Investigational new drugs Sep, 2006 | Pubmed ID: 16528478
Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases.
BMC cancer May, 2006 | Pubmed ID: 16674812
Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study.
BMC cancer Oct, 2006 | Pubmed ID: 17026776
Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha.
BJU international Jun, 2007 | Pubmed ID: 17346275
Pancreatic stellate cells: partners in crime with pancreatic cancer cells.
Cancer research Apr, 2008 | Pubmed ID: 18381413
Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?
Australian health review : a publication of the Australian Hospital Association Aug, 2008 | Pubmed ID: 18666870
Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance.
Cancer research Oct, 2008 | Pubmed ID: 18829522
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.
Cancer chemotherapy and pharmacology Mar, 2011 | Pubmed ID: 20461378
Role of pancreatic stellate cells in pancreatic cancer metastasis.
The American journal of pathology Nov, 2010 | Pubmed ID: 20934972
Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility.
The oncologist , 2011 | Pubmed ID: 21478275
Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity.
PloS one , 2011 | Pubmed ID: 21494615
If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer.
The oncologist , 2011 | Pubmed ID: 21835897
Impact of oxaliplatin-induced neuropathy: a patient perspective.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Mar, 2012 | Pubmed ID: 22426503
New molecular and immunotherapeutic approaches in biliary cancer.
ESMO open , 2017 | Pubmed ID: 28848675
Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2012 | Pubmed ID: 22508807
The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
Digestive diseases and sciences Aug, 2012 | Pubmed ID: 22543885
STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review).
International journal of oncology Oct, 2012 | Pubmed ID: 22842992
Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers.
Molecular pharmaceutics Jun, 2013 | Pubmed ID: 23611705
Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis.
Journal of cancer research and clinical oncology Nov, 2013 | Pubmed ID: 23912151
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2013 | Pubmed ID: 24002504
Clinical and molecular characterization of HER2 amplified-pancreatic cancer.
Genome medicine , 2013 | Pubmed ID: 24004612
Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer.
Frontiers in physiology , 2014 | Pubmed ID: 24478715
Chemotherapy-induced peripheral neurotoxicity: a critical analysis.
CA: a cancer journal for clinicians Nov-Dec, 2013 | Pubmed ID: 24590861
Role of pancreatic stellate cells in chemoresistance in pancreatic cancer.
Frontiers in physiology , 2014 | Pubmed ID: 24782785
The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.
Carcinogenesis Aug, 2014 | Pubmed ID: 24876152
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations.
Genetics in medicine : official journal of the American College of Medical Genetics May, 2015 | Pubmed ID: 25188872
Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
Anticancer research Nov, 2014 | Pubmed ID: 25368256
βIII-tubulin: a novel mediator of chemoresistance and metastases in pancreatic cancer.
Oncotarget Feb, 2015 | Pubmed ID: 25544769
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial.
Journal of the National Cancer Institute Feb, 2015 | Pubmed ID: 25638248
The Potential of panHER Inhibition in Cancer.
Frontiers in oncology , 2015 | Pubmed ID: 25674538
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.
European journal of cancer (Oxford, England : 1990) May, 2015 | Pubmed ID: 25801699
Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables.
The oncologist May, 2015 | Pubmed ID: 25802406
Targeted therapy in soft tissue sarcoma-a novel direction in therapeutics.
Chinese clinical oncology Sep, 2013 | Pubmed ID: 25841678
"I might not have cancer if you didn't mention it": a qualitative study on information needed by culturally diverse cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jan, 2016 | Pubmed ID: 26093976
A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services.
Psycho-oncology Feb, 2016 | Pubmed ID: 26123474
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.
BMC cancer Jul, 2015 | Pubmed ID: 26228433
Response.
Journal of the National Cancer Institute Sep, 2015 | Pubmed ID: 26251330
Key role of pancreatic stellate cells in pancreatic cancer.
Cancer letters 10, 2016 | Pubmed ID: 26571462
Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?
European journal of cancer (Oxford, England : 1990) Jan, 2016 | Pubmed ID: 26702763
Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.
British journal of cancer Feb, 2016 | Pubmed ID: 26766740
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.
BMC cancer Jan, 2016 | Pubmed ID: 26772734
Using a Delphi process to determine optimal care for patients with pancreatic cancer.
Asia-Pacific journal of clinical oncology Jun, 2016 | Pubmed ID: 26800012
Overcoming resistance of targeted EGFR monotherapy by inhibition of STAT3 escape pathway in soft tissue sarcoma.
Oncotarget Apr, 2016 | Pubmed ID: 26909593
Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 08, 2016 | Pubmed ID: 27086312
Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.
American journal of human genetics 05, 2016 | Pubmed ID: 27108799
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
JAMA May, 2016 | Pubmed ID: 27139057
Erratum to: Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Aug, 2016 | Pubmed ID: 27154013
Determinants of Outcomes Following Resection for Pancreatic Cancer-a Population-Based Study.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 08, 2016 | Pubmed ID: 27184672
Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus.
The Medical journal of Australia Jun, 2016 | Pubmed ID: 27318402
Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.
Cancer chemotherapy and pharmacology Jan, 2017 | Pubmed ID: 27497971
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence.
OncoTargets and therapy , 2016 | Pubmed ID: 27660463
Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines.
Anticancer research 11, 2016 | Pubmed ID: 27793898
Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review.
Asia-Pacific journal of clinical oncology Oct, 2017 | Pubmed ID: 27860270
MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity.
Oncotarget Feb, 2017 | Pubmed ID: 27999205
Communicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionals.
European journal of oncology nursing : the official journal of European Oncology Nursing Society Feb, 2017 | Pubmed ID: 28069155
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.
European journal of cancer (Oxford, England : 1990) 03, 2017 | Pubmed ID: 28104535
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy.
PloS one , 2017 | Pubmed ID: 28125674
Anxiety, depression and quality of life in people with pancreatic cancer and their carers.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] Mar - Apr, 2017 | Pubmed ID: 28153446
Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients.
Health expectations : an international journal of public participation in health care and health policy 10, 2017 | Pubmed ID: 28261937
The role of chemotherapy in gastric cancer-related microangiopathic haemolytic anaemia.
Journal of gastrointestinal oncology Feb, 2017 | Pubmed ID: 28280630
Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research.
Carcinogenesis 06, 2017 | Pubmed ID: 28379317
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials.
BMC cancer 04, 2017 | Pubmed ID: 28403829
Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue.
Journal of pain and symptom management 07, 2017 | Pubmed ID: 28502786
Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology Jul, 2017 | Pubmed ID: 28511129
Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma.
International journal of molecular sciences May, 2017 | Pubmed ID: 28556791
Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Nov, 2017 | Pubmed ID: 28589310
Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy.
Muscle & nerve Sep, 2017 | Pubmed ID: 28881477
Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice.
Muscle & nerve 04, 2018 | Pubmed ID: 28881481
Evaluating the Impact of Functional Genetic Variation on HIV-1 Control.
The Journal of infectious diseases 11, 2017 | Pubmed ID: 28968755
Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer.
Oncotarget Sep, 2017 | Pubmed ID: 29100344
Predictors of care for patients with cancer of unknown primary site in three Australian hospitals.
Asia-Pacific journal of clinical oncology Oct, 2018 | Pubmed ID: 29105289
Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?
ANZ journal of surgery 09, 2018 | Pubmed ID: 29514401
Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival.
Asia-Pacific journal of clinical oncology Aug, 2018 | Pubmed ID: 29573158
Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines.
International journal of oncology Jun, 2018 | Pubmed ID: 29620166
A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy.
Contemporary clinical trials 07, 2018 | Pubmed ID: 29680317
Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer May, 2019 | Pubmed ID: 30327877
Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture.
Neuroscience letters 02, 2019 | Pubmed ID: 30439399
Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review.
Journal of surgical oncology Mar, 2019 | Pubmed ID: 30636052
Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Oct, 2019 | Pubmed ID: 30756229
Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Dec, 2019 | Pubmed ID: 30972648
Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test.
Journal of cancer survivorship : research and practice Aug, 2019 | Pubmed ID: 31172429
Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients.
The journal of pain : official journal of the American Pain Society Jan - Feb, 2020 | Pubmed ID: 31325646
Optimizing Clinical Screening for Chemotherapy-Induced Peripheral Neuropathy.
Journal of pain and symptom management 12, 2019 | Pubmed ID: 31374367
Balance Deficits and Functional Disability in Cancer Survivors Exposed to Neurotoxic Cancer Treatments.
Journal of the National Comprehensive Cancer Network : JNCCN 08, 2019 | Pubmed ID: 31390588
The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy.
Acta oncologica (Stockholm, Sweden) Jan, 2020 | Pubmed ID: 31462137
Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review.
HPB : the official journal of the International Hepato Pancreato Biliary Association 02, 2020 | Pubmed ID: 31635959
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT).
Practical radiation oncology May - Jun, 2020 | Pubmed ID: 31761541
Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials.
Hematological oncology Aug, 2020 | Pubmed ID: 31873944
Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups.
Asia-Pacific journal of clinical oncology Jun, 2020 | Pubmed ID: 31957344
The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas.
Oncotarget Jan, 2020 | Pubmed ID: 32002123
Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis.
British journal of cancer May, 2020 | Pubmed ID: 32203220
The impact of anticancer drugs on the ocular surface.
The ocular surface 07, 2020 | Pubmed ID: 32344148
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer.
JAMA network open May, 2020 | Pubmed ID: 32407502
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer.
Journal of hepatology May, 2020 | Pubmed ID: 32446715
Stage pN3a in oral cancer: A redundant entity?
Oral oncology May, 2020 | Pubmed ID: 32467072
Acute changes in nerve excitability following oxaliplatin treatment in mice.
Journal of neurophysiology 07, 2020 | Pubmed ID: 32519566
Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer.
Pancreas 07, 2020 | Pubmed ID: 32541630
Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy-a randomised controlled trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jun, 2020 | Pubmed ID: 32607598
Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study.
Cancer epidemiology Aug, 2020 | Pubmed ID: 32615538
Oxaliplatin-induced haematological toxicity and splenomegaly in mice.
PloS one , 2020 | Pubmed ID: 32877416
Tony C. Y. Pang1,2,4,5,
Zhihong Xu1,2,
Alpha Raj Mekapogu1,2,
Srinivasa Pothula1,2,
Therese M. Becker3,
David Goldstein1,
Romano C. Pirola1,2,
Jeremy S. Wilson1,2,
Minoti V. Apte1,2
1Pancreatic Research Group, South Western Sydney Clinical School, University of New South Wales,
2, Ingham Institute for Applied Medical Research,
3Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research,
4Surgical Innovations Unit, Westmead Hospital,
5Westmead Clinical School, University of Sydney
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved